Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V |
Lupus Nephritis | Phase2 |
Brazil China France Germany Hong Kong Hungary India Israel Malaysia Mexico Portugal Puerto Rico Singapore Spain Turkey United States View All
|
NCT05268289 |
|
A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China |
Retinopathy of Prematurity | China | NCT05576792 | |
|
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas |
Metastatic Uveal Melanoma | Phase1, Phase2 |
Australia France Germany Netherlands Spain Switzerland United States View All
|
NCT05415072 |
|
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. |
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers | Phase1 |
Belgium China France Germany Israel Italy Japan Korea, Republic of Norway Singapore Spain Sweden Taiwan United States View All
|
NCT05838768 |
|
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia |
Warm Autoimmune Hemolytic Anemia (wAIHA) | Phase3 |
Argentina Australia China France Germany Hungary India Israel Italy Japan Malaysia Romania Singapore Spain Taiwan Thailand United Kingdom United States View All
|
NCT05648968 |
|
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). |
Systemic Lupus Erythematosus | Phase3 |
Australia Canada China Czechia Germany Hungary Japan Malaysia Poland Spain Taiwan Thailand United States View All
|
NCT06133972 |
|
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS |
Atypical Hemolytic Uremic Syndrome | Phase3 |
Brazil India |
NCT05795140 |
|
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL |
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Large B-cell Lymphoma | Phase1, Phase2 |
Australia Austria France Germany Italy Japan Spain United States View All
|
NCT03960840 |
|
Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR |
Giant Cell Arteritis, Polymyalgia Rheumatica | Phase1 |
Czechia Italy Portugal Spain Switzerland United States View All
|
NCT06130540 |
|
A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China |
Chronic Spontaneous Urticaria | China | NCT06053801 |